Remove Biotechnology Remove Healthcare Remove Life Sciences
article thumbnail

JPMorgan Establishes Life Sciences Private Equity Division

HIT Consultant

Morgan Asset Management announced the establishment of a new life sciences private equity team, Life Sciences Private Capital. – The Life Sciences Private Capital team will sit within J.P. . – The Life Sciences Private Capital team will sit within J.P. Anya Schiess.

article thumbnail

Healthcare & Life Science M&A Activity Plummets 1H’22

HIT Consultant

What You Should Know: – The index of Healthcare & Life Science equities tracked by Stout was down 16.8% – Healthcare & Life Science M&A activity plummeted to 338 deals in Q2 2022 versus 535 in Q2 2021 and a record 565 deals in Q4 2021. Key Trends and Market Summary. from $34.61

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Phenomix Sciences, InformedDNA Integrate to Advance Genetics-Driven Obesity Care

HIT Consultant

What You Should Know: – Phenomix Sciences , a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, announces a new partnership to advance precision medicine in obesity with InformedDNA, the nation’s leading applied genomics solutions company.

article thumbnail

Verana Health Raises $150M to Expand Real-World Data Network

HIT Consultant

Empowering Physicians & Life Science Companies. In October 2021, Verana Health launched its VeraQ™ population health data engine, which is clinician-directed and enhanced by AI to securely power a data integrity feedback loop of nearly a half-billion, de-identified healthcare encounters. Strategic Partners. Expansion Plans.

article thumbnail

How are drugs developed and financed? An overview

Healthcare ECONOMIST

Biotechnology companies (biotech) or small/medium-sized biopharmaceutical companies (SMEs) are most active in drug discovery, preclinical development and early-stage clinical development. About two-thirds comes from private sector life sciences companies. The paper also lists 7 different archetypes for drug development.

article thumbnail

GoMo Health Acquires Trajectory, a Specialist Health and Wellness Agency

GoMoHealth

A leader in designing and implementing personalized engagement solutions that support clients across the healthcare and wellness continuum, its’ solutions are highly scalable and cost-effective, enabling better self- management, healthy decisions making, and improved outcomes for patients, members, and employees.

article thumbnail

Quantiphi Invests in Transcell to Advance AI-Driven Drug Discovery

HIT Consultant

This collaboration marks a significant step forward in the integration of AI and biotechnology for drug discovery and development. The company’s investment in Transcell further solidifies its position as a leader in the healthcare and life sciences industry.